Tenet Healthcare price target raised to $194 from $184 at Mizuho

Mizuho raised the firm’s price target on Tenet Healthcare (THC) to $194 from $184 and keeps an Outperform rating on the shares as part of a Q2 earnings preview. The firm believes earnings visibility is solid for the hospital group while cost trends remain challenging for managed care companies. Mizuho says its survey of 215 physicians is positive for hospitals, neutral for clinical labs, and neutral-to-negative for managed care.